Explore more
News
Cigna, Zepbound
Digest more
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers ...
The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...
Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...
Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...
The Cigna Group is the latest company accused of mismanaging the forfeited funds in its 401(k) plan, and software company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback